AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$1.50 USD
+0.12 (8.70%)
Updated May 29, 2024 04:00 PM ET
After-Market: $1.50 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | 9.68% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.80 |
Next Year | -0.87 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.22 | -3.80 | -0.87 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.19 | -0.22 | NA | -0.87 |
High Estimate | -0.19 | -0.22 | -3.80 | -0.87 |
Low Estimate | -0.19 | -0.22 | -3.80 | -0.87 |
Year ago EPS | NA | NA | NA | -3.80 |
Year over Year Growth Est. | NA | NA | NA | 77.11% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.22 | -3.80 | -0.87 |
7 Days Ago | -0.19 | -0.22 | -3.80 | -0.87 |
30 Days Ago | -0.31 | -0.32 | -1.18 | -1.16 |
60 Days Ago | -0.43 | -0.31 | -1.54 | -1.42 |
90 Days Ago | -0.43 | -0.31 | -1.54 | -1.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.22 | -3.80 | -0.87 |
Zacks Consensus Estimate | -0.19 | -0.22 | -3.80 | -0.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.71 | NA | NA | NA |
Estimate | -0.31 | -0.40 | NA | NA | NA |
Difference | 0.03 | -0.31 | NA | NA | -0.14 |
Surprise | 9.68% | -77.50% | NA | NA | -33.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more